Key Highlights

  • Ultralife Corporation (NASDAQ:ULBI) changed hands at USD 15.51 in pre-market dealings on Wednesday, October 28, 2026, a rise of 143.87%. The move followed the company's announcement on Tuesday, October 27, 2026 that EnerSys will purchase it for USD 16.00 per share in cash.
  • For the quarter ended Tuesday, June 30, 2026, Ultralife Corporation (NASDAQ:ULBI) booked revenue of USD 47.9 million, a 1.3% decline, earnings of USD 0.15 per share and adjusted EBITDA of USD 6.1 million. Its backlog stood at a record USD 117.5 million.
  • The transaction is worth roughly USD 320 million including net debt the buyer will take on. It carries no financing condition, and closing is targeted for the first quarter of calendar 2027, pending a tender offer and regulators' approval.
  • The pre-market quote sits about 3.1% under the USD 16.00 offer. Because the tender offer has yet to begin, the stock's direction now depends on whether the deal completes, and thin pre-market trading adds noise.

What Sent the Stock Higher Before the Open

Ultralife Corporation (NASDAQ:ULBI) makes batteries, energy products and communications systems. In pre-market trading on Wednesday, October 28, 2026 it reached USD 15.51, up 143.87% on the pre-market quote. The driver was the company's Tuesday, October 27, 2026 release, which said EnerSys will acquire every outstanding share for USD 16.00 in cash. That release describes the price as a 166% premium over the close on Monday, October 26, 2026. Working backward, the premium points to a prior close near USD 6.02, while the pre-market gain points to about USD 6.36, so the prior close falls between USD 6.02 and USD 6.36. Total transaction value, including assumed net debt, is about USD 320 million. Pre-market quotes can shift before the 9:30 a.m. ET open.

What the Recent Financials Say About the Offer Price

Ultralife Corporation (NASDAQ:ULBI) posted second-quarter results on Friday, August 7, 2026. Revenue reached USD 47.9 million, down 1.3% year on year, and earnings were USD 0.15 per share, compared with USD 0.05. Gross profit came to USD 13.9 million, a 28.9% margin. Adjusted EBITDA, which is earnings before interest, tax, depreciation and amortisation with one-off items stripped out, was USD 6.1 million compared with USD 4.1 million, and backlog hit a record USD 117.5 million. On Tuesday, June 30, 2026, cash stood at USD 6.7 million and total debt at USD 44.6 million. Because the cash offer fixes the price, the shares now trade mainly on the likelihood and timing of completion rather than on these figures.

Downside Scenarios and Key Dates

The optimistic view is that a pre-market price only about 3.1% beneath the offer, a simple calculation on two published numbers, points to strong confidence that the deal closes. The cautious view is that the tender offer has not started and must draw a majority of outstanding shares, plus regulatory clearance. If either condition fails, the stock could drift back toward its level before the announcement. Specific risks include timing, since closing is only expected in the first quarter of calendar 2027, antitrust review and thin pre-market volume. Investors should follow the launch of the tender offer, the Federal Reserve decision scheduled for later on Wednesday, October 28, 2026, and the regulatory filings that come after.

Where Things Stand

Ultralife Corporation (NASDAQ:ULBI) moved higher before the open on Wednesday, October 28, 2026, because EnerSys committed on Tuesday, October 27, 2026 to acquire it for USD 16.00 a share in cash. The roughly USD 320 million deal value, debt included, frames most of the story. Next come the launch of the tender offer, the Federal Reserve decision later on Wednesday, October 28, 2026 and the targeted first-quarter 2027 close. Pre-market figures shift constantly, and nothing here is investment advice.